JPS6154006B2 - - Google Patents

Info

Publication number
JPS6154006B2
JPS6154006B2 JP53159066A JP15906678A JPS6154006B2 JP S6154006 B2 JPS6154006 B2 JP S6154006B2 JP 53159066 A JP53159066 A JP 53159066A JP 15906678 A JP15906678 A JP 15906678A JP S6154006 B2 JPS6154006 B2 JP S6154006B2
Authority
JP
Japan
Prior art keywords
salt
chloroethyl
acid
oxo
oxyazaphosphorinane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53159066A
Other languages
English (en)
Japanese (ja)
Other versions
JPS54101432A (en
Inventor
Burotsuku Noruberuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASUTAAUERUKE AG HEMITSUSHE FUABURIIKU
Original Assignee
ASUTAAUERUKE AG HEMITSUSHE FUABURIIKU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2756018A external-priority patent/DE2756018C2/de
Application filed by ASUTAAUERUKE AG HEMITSUSHE FUABURIIKU filed Critical ASUTAAUERUKE AG HEMITSUSHE FUABURIIKU
Publication of JPS54101432A publication Critical patent/JPS54101432A/ja
Publication of JPS6154006B2 publication Critical patent/JPS6154006B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
JP15906678A 1977-12-14 1978-12-13 Detoxication of cell propagation controlling agent Granted JPS54101432A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2756018A DE2756018C2 (de) 1977-12-14 1977-12-14 Verwendung von Salzen von Mercaptoalkansulfonsäuren
DE2827625 1978-06-23

Publications (2)

Publication Number Publication Date
JPS54101432A JPS54101432A (en) 1979-08-10
JPS6154006B2 true JPS6154006B2 (enExample) 1986-11-20

Family

ID=25773277

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15906678A Granted JPS54101432A (en) 1977-12-14 1978-12-13 Detoxication of cell propagation controlling agent

Country Status (6)

Country Link
US (1) US4220660A (enExample)
EP (1) EP0002495B1 (enExample)
JP (1) JPS54101432A (enExample)
DK (1) DK154608C (enExample)
FI (1) FI783756A7 (enExample)
NO (1) NO784192L (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01174407U (enExample) * 1988-05-26 1989-12-12

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA851062B (en) * 1984-03-01 1985-11-27 Asta Werke Ag Chem Fab Salts of oxazaphosphorine derivatives and process for their production
US5244920A (en) * 1985-04-15 1993-09-14 Schering Spa Pharmaceutical compositions having therapeutical activity based on mercaptoethansulphonic arginine salt
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
DE58900183D1 (de) * 1988-03-19 1991-08-29 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US6197831B1 (en) * 1999-02-09 2001-03-06 Bionumerik Pharmaceuticals, Inc. Method of treating septic shock
US6077838A (en) * 1999-06-08 2000-06-20 Bionumerik Pharmaceuticals, Inc. Method of treating hangover
WO2001049822A2 (en) * 1999-12-29 2001-07-12 Sergei Mikhailovich Zenovich Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy
US6245815B1 (en) * 2000-04-15 2001-06-12 Bionumerik Pharmaceuticals, Inc. Method of treating alcoholism and complications resulting therefrom
US6291441B1 (en) * 2000-09-27 2001-09-18 Frederick H. Hausheer Method of treating inflammatory bowel disorders
US6352979B1 (en) * 2001-08-20 2002-03-05 Lucinda Lizcano Method of treating snakebite and complications resulting therefrom
NZ538584A (en) * 2002-09-05 2007-05-31 Bharat Serums & Vaccines Ltd Stable liquid composition of oxazaphosphorine, mesna and etherified beta-cyclodextrin
US7025998B2 (en) 2003-05-30 2006-04-11 Rotta Research Laboratorium S.P.A. Phytoestrogens and probiotic for women's health
JP4886517B2 (ja) * 2003-10-01 2012-02-29 バクスター・インターナショナル・インコーポレイテッド 新たな用途の薬学的調製物およびその調製物を製造するためのプロセス
JP4936898B2 (ja) * 2003-12-17 2012-05-23 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド ジスルフィド類の合成方法
US20060063742A1 (en) * 2004-09-21 2006-03-23 Hausheer Frederick H Method of treatment for or protection against lymphedema

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1119721A (en) * 1965-05-07 1968-07-10 Ucb Sa Mucolytic mercapto-sulphonates

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01174407U (enExample) * 1988-05-26 1989-12-12

Also Published As

Publication number Publication date
JPS54101432A (en) 1979-08-10
DK154608B (da) 1988-12-05
FI783756A7 (fi) 1979-06-15
DK553978A (da) 1979-06-15
DK154608C (da) 1989-05-08
NO784192L (no) 1979-06-15
EP0002495B1 (de) 1984-02-15
EP0002495A1 (de) 1979-06-27
US4220660A (en) 1980-09-02

Similar Documents

Publication Publication Date Title
JPS6154006B2 (enExample)
HK162895A (en) A locally administrable therapeutic composition for inflammatory disease
US5470883A (en) Method of treating peripheral vasoconstriction with tamoxifen citrate
AT393221B (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
JPS60100517A (ja) 放射線潰瘍治療剤および方法
BG65847B1 (bg) Приложение на производни на бигуанидина за получаване на лекарствено средство с цикатризиращ ефект
US4291030A (en) Method of lowering blood cholesterol
US4218471A (en) Process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents
EP0542807B1 (en) Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one
US5385726A (en) Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
JP2025011312A (ja) ｐ－ボロノフェニルアラニンを含有する注射液剤の析出防止方法
KR20220004640A (ko) 운동이상증 치료 약물
CA1117015A (en) Process for producing detoxified pharmaceutical products containing a cytostatically active alkylating agent
RU2703735C1 (ru) Фармацевтическая композиция, содержащая DHMEQ или его аналоги
EP4574144A1 (en) Method for treating peripheral nerve sheath tumor
US2497742A (en) Sclerosing composition
AU2023285788A1 (en) Method for treating peripheral nerve sheath tumor
JPH1179991A (ja) 移植皮膚又は移植組織の壊死防止剤
JP2025084138A (ja) 悪性末梢神経鞘を治療するための方法
PT1553938E (pt) Utilização de derivados de epotilona para o tratamento do hiperparatiroidismo
CN118265534A (zh) Ws635在医药中的用途
Saleh et al. Effect of cysteine on the hepatic toxicity and antischistosomal activity of antimonyl potassium tartrate
WO2006034325A2 (en) Method of treatment for or protection against lymphedema
JPWO2005000293A1 (ja) 脳血管障害に伴う過活動膀胱治療剤
JPWO1998027982A1 (ja) アスコルビン酸含有組成物